JUL 27, 2015 1:31 PM PDT

Protein Imbalance Can Cause Cancer

WRITTEN BY: Ilene Schneider
While most scientists have viewed genetic aberrations as the primary cause of almost all cancer, a new study of ovarian cancer at the University of Leeds in the United Kingdom and the University of Texas MD Anderson Cancer Center suggests that cancer may be caused "solely by protein imbalances within cells." Published in the journal Oncogene and reported in Science Daily, the research shows how "protein imbalance is a powerful prognostic tool, indicating whether or not patients are likely to respond to chemotherapy and whether a tumor is likely to spread to other sites." This study could also lead to new therapies designed to measure and prevent dangerous protein imbalances in cells, the article explains (http://www.sciencedaily.com/releases/2015/07/150727092537.htm).
Cancer can have non-genetic causes.
According to the American Cancer Society, cancer, the second most common cause of death in the US, accounts for nearly one of every four deaths. The World Health Organization estimates that, worldwide, there were 4 million new cancer cases and 8.2 million cancer-related deaths in 2012 (http://www.medicalnewstoday.com/info/cancer-oncology/).

According to the lead author, Professor John Ladbury, Dean of the University of Leeds' Faculty of Biological Sciences and Professor of Mechanistic Biology, "There has been huge investment in sequencing the human genome with the idea that if we get all the relevant genetic information we can predict whether you have a predisposition to cancer and, ultimately, use a precision medicine-based approach to develop a therapeutic approach. Our study demonstrates that genetic screening alone is not enough."

The study concentrated on the "Akt pathway," a signaling pathway inside cells that drives cancer formation and the spread of cancers through the body. Normally, the cell would get external signals by means of a cell wall-bound receptor (FGFR2, in this research). Because of this stimulus, the receptor becomes "switched on" inside the cell, thus triggering the recruitment of signaling proteins and the initiation of the Akt pathway, which has the function of getting the cell to proliferate. According to the article, "In some cancerous cells, this pathway is permanently switched on. A conventional approach to diagnosing this cancer would be to look for genetic modification of the receptor (or recruited proteins), which could be responsible for maintaining the switched on state."

The researchers studied isolated cancer cells that did not have external stimulation and determined that the "Akt pathway" could be set in motion without genetic modifications. They found that two proteins -- Plc?1 and Grb2 -- compete for attaching to FGFR2. The relative concentration of these proteins determines which one does the binding. When Plc?1 succeeds, it stimulates the Akt pathway. Thus, an imbalance in the amount of the two proteins can trigger cell replication and cancer formation.

Now the researchers are studying the same mechanisms in other kinds of cancer. In addition, they are looking at other cell receptors that might play a role in sustaining oncogenic signaling without being activated.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 14, 2020
Genetics & Genomics
Why Defects in One Gene Can Lead to Cancer in Kids
SEP 14, 2020
Why Defects in One Gene Can Lead to Cancer in Kids
While they may occur in adults, a rare, aggressive type of brain cancer called atypical teratoid rhabdoid tumors tend to ...
SEP 18, 2020
Coronavirus
How Coronavirus Spread in the US and Europe
SEP 18, 2020
How Coronavirus Spread in the US and Europe
Researchers are beginning to examine how the world's response to the pandemic virus SARS-CoV-2 went wrong, and right ...
SEP 25, 2020
Clinical & Molecular DX
Ray of Hope: Rare Cancer Biomarker Discovered
SEP 25, 2020
Ray of Hope: Rare Cancer Biomarker Discovered
Biliary tract cancer, or BTC, isn’t as talked about as breast or prostate cancers, probably because its incidence ...
OCT 16, 2020
Cancer
Chronic jet lag raises cancer risk
OCT 16, 2020
Chronic jet lag raises cancer risk
We all know how horrible it feels to have a bad night of sleep. That feeling is only intensified with jet lag because ou ...
OCT 21, 2020
Cancer
Can Excess Fructose Cause Liver Cancer?
OCT 21, 2020
Can Excess Fructose Cause Liver Cancer?
Hepatocellular carcinoma, aka liver cancer, is an ever-increasing issue in the western world. While the lion’s sha ...
NOV 04, 2020
Cancer
Building a New Chemotherapy Drug
NOV 04, 2020
Building a New Chemotherapy Drug
For decades, modern medicine has relied on chemists’ work to produce compounds that could one day be used as a dru ...
Loading Comments...